首页> 外文期刊>Lung India >Multidrug resistance in tubercular mediastinal adenopathy diagnosed by endobronchial ultrasound-transbronchial needle aspiration
【24h】

Multidrug resistance in tubercular mediastinal adenopathy diagnosed by endobronchial ultrasound-transbronchial needle aspiration

机译:结核超声跨晶针诊断患有结核纵隔腺肿的多药耐药性

获取原文
       

摘要

Background: Drug resistance in tuberculosis (TB) is a major public health problem. It is easy to assess for drug resistance in pulmonary samples, but the resistance pattern of TB in the mediastinal nodes has not been studied. The aim of this study is to assess the incidence of multidrug resistance in tubercular mediastinal adenopathy with the help of endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration. Materials and Methods: This was a prospective study at a tertiary care teaching hospital in New Delhi where 102 patients with positive mycobacterial cultures from mediastinal lymph node aspirates taken with the help of EBUS were enrolled over 24 months and their drug sensitivity to the first-line antitubercular drugs analyzed. Results: There were 30 cases of drug resistance of 102 culture-positive cases. Of them, 8 patients had multidrug resistant TB (MDR-TB), 16 cases had only single drug resistance, and the remaining 6 cases had more than one drug resistance pattern but not MDR. In our study, the overall incidence of MDR-TB is 7.8% (8/102), although the incidence of MDR-TB in new and re-treatment cases is 2.2% (2/89) and 46.1% (6/13), respectively. Conclusion: Such a high percentage of drug-resistant patients is common in tertiary care hospitals; however, similar percentages may be found in other settings as well. Therefore, all efforts should be made to take samples for Mycobacterium tuberculosis culture from the involved nodes before commencing therapy to avoid treatment failures.
机译:背景:结核病(TB)的耐药性是一个主要的公共卫生问题。易于评估肺样品中的耐药性,但尚未研究纵隔节点中TB的电阻模式。本研究的目的是利用内核超声波(EBUS) - 导向横切针吸入的帮助,评估结核纵隔腺肿的多药耐药性的发生率。材料和方法:这是新德里高等教育教学医院的前瞻性研究,其中102名来自EBUS的纵隔淋巴结吸气患者患有eBus的患者,注册了24个月,其对一线的药物敏感性分析抗结核药物。结果:102例培养阳性病例有30例耐药性。其中,8例患者具有多药TB(MDR-TB),16例只有单一的耐药性,剩余的6例具有多种耐药图案但没有MDR。在我们的研究中,MDR-TB的总发病率为7.8%(8/102),尽管MDR-TB在新的和重新治疗病例中的发病率为2.2%(2/89)和46.1%(6/13) , 分别。结论:如此高比例的耐药患者在大专院医院常见;但是,可以在其他设置中找到类似的百分比。因此,应在开始治疗之前从所涉及的节点从所涉及的节点中对所有努力进行所有努力,以避免治疗失败。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号